Blood markers may spot colorectal cancer earlier
NCT ID NCT07414082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if measuring two proteins in the blood, Talin-1 and Cripto-1, can help diagnose colorectal cancer. Researchers will compare these levels in 70 newly diagnosed patients and healthy people. The goal is to find a simpler, more accurate way to detect the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit University Hospital
Asyut, Asyut Governorate, 17777, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a registry make endoscopic procedures safer and more effective?
- A new clue in the fight against colorectal cancer recurrence?
- One simple score to rate colorectal cancer surgery quality?
- Engineered virus joins forces with immunotherapy to fight resistant cancers
- Massive 30-Year Women's health study reveals hidden disease links